High-Frequency Migraine Refractory to Usual Pharmacological Treatment and Antibody and Responsive to Full-Spectrum Cannabidiol: A Case Report. Headache Med 2022, 13 (3), 229-232. https://doi.org/10.48208/HeadacheMed.2022.26.